Login to Your Account



Other News To Note


Thursday, October 4, 2012
• Epizyme Inc., of Cambridge, Mass., disclosed $4 million in milestone payments from collaborator GlaxoSmithKline plc, of London, based on achieving preclinical goals.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription